Initial Approaches In Locally Advanced Hcc

Summary

Panelists Richard S. Finn, MD; Jordi Bruix, MD; and Richard H. Marshall, MD, share their Richard Finn, MD, provides insight on some of the Catherine T. Frenette, MD, and Darren S. Sigal, MD, talk about the ... candidacy in patients, and an overview of the available treatment options for Ghassan K. Abou-Alfa, MD; Richard S. Finn, MD; Arndt Vogel, MD; and Masatoshi Kudo, MD, PhD, review the clinical significance ... This video is part of the HMP Education content archive and may include previously accredited educational material. While this ... Chair, Matthew S. Johnson, MD, FSIR, discusses Anthony El-Khoueiry, MD, discusses curative options in a 63-year-old patient with Chair and Presenter, Riad Salem, MD, MBA, Lipika Goyal, MD, MPhil, and Amit Singal, MD, MS, discuss Evidence-Based Treatment Selection and Sequencing in Dr. Mark Yarchoan from Johns Hopkins University presents on immunotherapy ... study Checkmate 90w essentially uh uh uh Nevo plus AP versus seraphene Orland as Dr. Pierce Chow discusses SIRT versus Sorafenib in We sat down with Dr. Edward Kim from Mount Sinai Hospital in New York/US to discuss the current role of TARE in